Ocular Therapeutix Inc
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 306,542
Bid Price 3.15
Ask Price 4.24
News -
Day High 3.91


52 Week Range


Day Low 3.78
Company Name Stock Ticker Symbol Market Type
Ocular Therapeutix Inc OCUL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 3.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.87 3.78 3.91 3.88 3.88
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,842 306,542 $ 3.86 $ 1,184,494 - 2.57 - 6.525
Last Trade Time Type Quantity Stock Price Currency
16:37:15 8 $ 3.88 USD


Draw Mode:

Ocular Therapeutix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 298.80M 77.01M 70.73M $ 43.52M $ -40.72M -0.95 -3.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 43.33k 3.10%

more financials information »

Ocular Therapeutix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OCUL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.124.123.743.89591,555-0.24-5.83%
1 Month2.874.222.773.75657,6701.0135.19%
3 Months3.524.222.573.20651,3610.3610.23%
6 Months4.456.5252.574.15749,984-0.57-12.81%
1 Year5.356.5252.574.20689,228-1.47-27.48%
3 Years4.3324.302.579.62902,902-0.45-10.39%
5 Years5.5724.302.358.27754,345-1.69-30.34%

Ocular Therapeutix Description

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application.